Skip to main content
Back to News

News From Around the System

New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma

UCLA Health — April 9, 2021

LOS ANGELES — Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimizes treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's…

New remote patient-care technology assists patients using neuromodulation therapy

UC Davis Health — April 9, 2021

The Deep Brain Stimulation (DBS) Program at UC Davis Health has a new tool to treat patients receiving neuromodulation therapy for movement disorders. Abbott’s NeuroSphere Virtual Clinic is a first-of-its-kind remote patient care system. UC Davis Health is the first hospital in Northern California and among the first 10 in…

UC Davis Medical Center

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts